SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-008220
Filing Date
2020-09-08
Accepted
2020-09-08 16:28:36
Documents
12
Period of Report
2020-09-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_090320.htm   iXBRL 8-K 38934
  Complete submission text file 0001387131-20-008220.txt   213897

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20200903.xsd EX-101.SCH 3225
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20200903_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20200903_pre.xml EX-101.PRE 22736
5 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_090320_htm.xml XML 3595
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 201164443
SIC: 2834 Pharmaceutical Preparations